Home/Filings/4/0001104659-16-140288
4//SEC Filing

Vitae Pharmaceuticals, Inc 4

Accession 0001104659-16-140288

CIK 0001157602operating

Filed

Aug 16, 8:00 PM ET

Accepted

Aug 17, 5:09 PM ET

Size

7.3 KB

Accession

0001104659-16-140288

Insider Transaction Report

Form 4
Period: 2016-08-15
Fratamico Arthur
Chief Business Officer
Transactions
  • Award

    Common Stock

    2016-04-29$6.11/sh+2,086$12,74512,086 total
  • Award

    Employee Stock Option (Right to Buy)

    2016-08-15+14,50014,500 total
    Exercise: $8.79Exp: 2026-08-14Common Stock (14,500 underlying)
Footnotes (2)
  • [F1]The Reporting Person acquired 2,086 shares of Common Stock pursuant to the Vitae Pharmaceuticals, Inc. 2014 Employee Stock Purchase Plan.
  • [F2]This option shall vest with respect to 25% of the shares of stock which are subject to this option on August 15, 2017 (the "Initial Vesting Date") and 1/48th of the shares of stock which are subject to this option monthly following the Initial Vesting Date.

Documents

1 file

Issuer

Vitae Pharmaceuticals, Inc

CIK 0001157602

Entity typeoperating

Related Parties

1
  • filerCIK 0001157602

Filing Metadata

Form type
4
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 5:09 PM ET
Size
7.3 KB